Lilly’s basal insulin peglispro proved more effective than the $7 billion blockbuster Lantus at controlling diabetics’ blood sugar, but it also had greater effect on patients’ livers and hearts. Analysts are unsure of its future.
The new version of the Healthy Indiana Plan, backed by Obamacare funding, has enrolled 229,000 new participants in four months without breaking stride.
Wall Street analysts say a purchase of Louisville-based Humana Inc., which reportedly has put itself up for sale, would by Indianapolis-based Anthem. An Anthem-Humana marriage would be the biggest merger in the history of U.S. health insurance.
It took $394,000 to rank in the top 1 percent of U.S. earners in 2013. And more than 100 of the Indiana contingent in that exclusive club were physicians employed by one of the four major hospital systems that operate in the Indianapolis area.
The individual hospital campuses around Indianapolis saw their collective revenue rise 8 percent and their collective operating profits rise 22 percent from from 2011 to 2013. That’s solid, just not stellar, growth.
In Indiana, Anthem has struck accountable care organization deals with 14 health care provider groups and signed up nearly 2,900 primary care providers to its medical home program. And it’s pushing for more in the future.
For employer health plans, diabetics generate $10,000 more per year in medical bills than non-diabetics. That means the rise in the prevalence of diabetes over the past 25 years is costing Hoosiers an extra $2.6 billion annually.
With a CEO hired and a soon-to-be signed lease for office space, the $360 million Indiana Biosciences Research Institute is ready to lift off.
Anthem Inc.’s brand has taken a noticeable hit since a massive data breach earlier this year, but the impact was blunted by positive perceptions of the way the company handled the breach.
That’s less than one-tenth of 1 percent of what Hoosiers and their health plans spend on hospital care each year. But it’s a step in the right direction.
Finding and supporting savvy people might result in more life sciences startups.
Hospital system tripled its profit last year by wooing patients to its physicians, trimming hospital and clinical staff by more than 400. The rating agency Moody’s says things look even better in 2015.
Indianapolis Business Journal gathered leaders in the state’s technology industry for a Power Breakfast panel discussion April 24. Among the topics the panel discussed were startup capital, attracting life sciences professionals and digital trends to watch.
A Health Department audit found nurse staffing routinely short on two patient units at IU Health’s Methodist hospital, where nurses are trying to organize a union.
The state has enjoyed success funding and building life sciences companies, and the new Indiana Biosciences Research Institute should give it a further boost, according to panelists Friday at IBJ's Life Sciences Power Breakfast.
To satisfy patients with high-deductible health plans, Northwest Radiology has introduced flat-rate pricing for its imaging scans. It’s a centuries-old concept among postal services, but for health care, it’s revolutionary.
The Indianapolis-based maker of genetically modified seed traits and weed killers said Thursday that it earned $409 million before interest, taxes, depreciation and amortization, down by 19 percent from the same quarter a year ago.
Environmentalists are contesting the federal government's decision to allow more widespread use of a new version of a popular weed killer to be used on genetically modified corn and soybeans.
Things got quiet after a wave of hospital systems' acquiring physician practices swept through central Indiana from 2008 to 2011. But a new wave could start now that Congress passed the "doc fix" last week.
A recent ranking of health care value in all 50 states puts Indiana in the basement. By my rough figures, working-age Hoosiers are paying a couple billions dollars extra for their health care.
